{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:24:39Z","timestamp":1786548279512,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41395-018-0248-8","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T07:50:58Z","timestamp":1540281058000},"page":"1660-1668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["An Assessment of Upper Limits of Normal for ALT and the Impact on Evaluating Natural Course of Chronic Hepatitis B Virus Infection in Chinese Children"],"prefix":"10.14309","volume":"113","author":[{"given":"Xiao-Ben","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Zhang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Chao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210302","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"R2-21-20210302","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840050315","article-title":"Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum.","volume":"5","author":"Chu","year":"1985","journal-title":"Hepatology"},{"key":"R3-21-20210302","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1002\/hep.20956","article-title":"Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005.","volume":"43","author":"Yim","year":"2006","journal-title":"Hepatology"},{"key":"R4-21-20210302","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection.","volume":"384","author":"Trepo","year":"2014","journal-title":"Lancet"},{"key":"R5-21-20210302","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection.","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"R6-21-20210302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-010-0304-7","article-title":"Natural history of hepatitis B virus infection: pediatric perspective.","volume":"46","author":"Ni","year":"2011","journal-title":"J Gastroenterol"},{"key":"R7-21-20210302","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1172\/JCI68182","article-title":"Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B.","volume":"123","author":"Publicover","year":"2013","journal-title":"J Clin Invest"},{"key":"R8-21-20210302","first-page":"398","article-title":"Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.","volume":"75","author":"Takashima","year":"1992","journal-title":"Immunology"},{"key":"R9-21-20210302","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1128\/JVI.76.4.1769-1780.2002","article-title":"Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation.","volume":"76","author":"Menne","year":"2002","journal-title":"J Virol"},{"key":"R10-21-20210302","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4049\/jimmunol.1303432","article-title":"T cells drive myeloid-derived suppressor cell-mediated CD8 T cell exhaustion in hepatitis B virus-induced immunotolerance.","volume":"193","author":"Kong","year":"2014","journal-title":"J Immunol"},{"key":"R11-21-20210302","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1084\/jem.20151218","article-title":"Interferon- facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance.","volume":"213","author":"Zeng","year":"2016","journal-title":"J Exp Med"},{"key":"R12-21-20210302","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2012.06.009","article-title":"Preserved T-cell function in children and young adults with immune tolerant chronic hepatitis B.","volume":"143","author":"Kennedy","year":"2012","journal-title":"Gastroenterology"},{"key":"R13-21-20210302","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27805","article-title":"Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells.","volume":"62","author":"Publicover","year":"2015","journal-title":"Hepatology"},{"key":"R14-21-20210302","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2016.07.012","article-title":"HBV DNA integration and clonal hepatocyte expansion in chronic hepatitis B patients considered immune tolerant.","volume":"151","author":"Mason","year":"2016","journal-title":"Gastroenterology"},{"key":"R15-21-20210302","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/cmi.2010.34","article-title":"Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAgHBeAg-mothers.","volume":"7","author":"Koumbi","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"R16-21-20210302","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1038\/ncomms7588","article-title":"Trained immunity in newborn infants of HBV-infected mothers.","volume":"6","author":"Hong","year":"2015","journal-title":"Nat Commun"},{"key":"R17-21-20210302","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection.","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"R18-21-20210302","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(98)80196-7","article-title":"HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B.","volume":"28","author":"Vingerhoets","year":"1998","journal-title":"J Hepatol"},{"key":"R19-21-20210302","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/clinchem\/21.8.1077","article-title":"Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values.","volume":"21","author":"Siest","year":"1975","journal-title":"Clin Chem"},{"key":"R20-21-20210302","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM198104233041701","article-title":"Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the transfusion-transmitted viruses study.","volume":"304","author":"Aach","year":"1981","journal-title":"N Engl J Med"},{"key":"R21-21-20210302","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jama.1981.03320060032017","article-title":"Donor transaminase and recipient hepatitis: impact on blood transfusion services.","volume":"246","author":"Alter","year":"1981","journal-title":"JAMA"},{"key":"R22-21-20210302","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/hep.23200","article-title":"Variability in the upper limit of normal for serum alanine aminotransferase levels: a statewide study.","volume":"50","author":"Dutta","year":"2009","journal-title":"Hepatology"},{"key":"R23-21-20210302","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1478-3231.2006.01197.x","article-title":"Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study.","volume":"26","author":"Kariv","year":"2006","journal-title":"Liver Int"},{"key":"R24-21-20210302","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MPG.0b013e31818fc63b","article-title":"Age- and sex-related reference ranges of alanine aminotransferase levels in children: European paediatric HCV network.","volume":"49","author":"England","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R25-21-20210302","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"R26-21-20210302","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1440-1746.2010.06481.x","article-title":"Healthy range for serum ALT and the clinical significance of unhealthy normal ALT levels in the Korean population.","volume":"26","author":"Kang","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R27-21-20210302","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","article-title":"SAFETY study: alanine aminotransferase cut off values are set too high for reliable detection of pediatric chronic liver disease.","volume":"138","author":"Schwimmer","year":"2010","journal-title":"Gastroenterology"},{"key":"R28-21-20210302","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG Clinical Guideline: evaluation of abnormal liver chemistries.","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R29-21-20210302","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/14787210.2015.1019867","article-title":"Hepatitis B virus infection in children.","volume":"13","author":"Komatsu","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R31-21-20210302","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1053\/j.gastro.2008.02.017","article-title":"The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.","volume":"134","author":"Zerbini","year":"2008","journal-title":"Gastroenterology"},{"key":"R32-21-20210302","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00535-017-1315-4","article-title":"Natural history of chronic hepatitis B virus infection in children in Japan: a comparison of mother-to-child transmission with horizontal transmission.","volume":"52","author":"Takano","year":"2017","journal-title":"J Gastroenterol"},{"key":"R33-21-20210302","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-3476(87)80338-4","article-title":"Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus.","volume":"111","author":"Chang","year":"1987","journal-title":"J Pediatr"},{"key":"R34-21-20210302","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.20006","article-title":"Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination.","volume":"39","author":"Chen","year":"2004","journal-title":"Hepatology"},{"key":"R35-21-20210302","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1440-1746.2003.02976.x","article-title":"Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy.","volume":"18","author":"Liaw","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"R36-21-20210302","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1053\/j.gastro.2008.02.075","article-title":"Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.","volume":"134","author":"Kumar","year":"2008","journal-title":"Gastroenterology"},{"key":"R37-21-20210302","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","article-title":"Evaluation of abnormal liver-enzyme results in asymptomatic patients.","volume":"342","author":"Pratt","year":"2000","journal-title":"N Engl J Med"},{"key":"R38-21-20210302","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.3390\/v9050096","article-title":"Immune tolerant chronic hepatitis B: the unrecognized risks.","volume":"9:pii","author":"Kennedy","year":"2017","journal-title":"Viruses"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0248-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0248-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/00000434-201811000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0248-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:24:22Z","timestamp":1786544662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201811000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1038\/s41395-018-0248-8","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}